Core Viewpoint - The A-share market has shown strong performance in 2023, particularly since July, with major indices reaching new highs, making it one of the best-performing markets globally in the third quarter [2][3]. Performance of Major Indices - The ChiNext Index led global performance with a year-to-date increase of 51.20% and a quarterly increase of 50.40% - The STAR 50 Index and the Shenzhen Component Index followed with increases of 51.20% and 29.88% respectively [3][4]. Private Equity Fund Performance - Among 2072 subjective long-only private equity products, only 149 (7.19%) outperformed the ChiNext Index in the third quarter [4][5]. - The average return for private equity products with assets over 2 billion was 83.02%, with the top 10 funds having a minimum return threshold of ***% [5][6]. Top Performing Private Equity Products - The top three funds in the over 2 billion category were: 1. "Ge Ru Qidian" managed by Shi Hao from Shanghai Ge Ru Private Equity, with a return of ***% [6][7]. 2. "Yuanxin China Active Growth C Class" managed by Wang Aoye from Yuanxin Investment, with a return of ***% [7][8]. 3. "Shengqi Baojian" managed by Cai Zhijun from Shengqi Asset, with a return of ***% [8]. Mid-Sized Private Equity Fund Performance - In the 500 million to 2 billion category, 50 funds outperformed the ChiNext Index, with an average return of 112.83% [9][10]. - The top three funds were: 1. "Xinchili Dingeng Selected 28" managed by Shen Longji [10][11]. 2. "Lanshi Zhixing No. 1" managed by Liu Yan [10]. 3. "Deyuan Yangfan No. 1" managed by Wu Zhou [10]. Small-Sized Private Equity Fund Performance - In the 0 to 500 million category, 77 funds outperformed the ChiNext Index, with an average return of 110.44% [12][13]. - The top three funds were: 1. "Zijun Yunsong" managed by Zou Kai from Hunan Zijun Private Equity [13][14]. 2. "Longhui Xiang No. 1" managed by Yang Zhongguang [13]. 3. "Wanghua Zhuoyue High Dividend Value Growth" managed by Qi Kexian [13].

Core Viewpoint - The A-share market has shown a steady upward trend in 2023, with the Shanghai Composite Index surpassing 3900 points, marking a nearly ten-year high. The private equity industry has also reported impressive performance, with an average return of 29.01% for private equity products in the first three quarters, significantly outperforming the 17.94% increase of the CSI 300 Index [2]. Group 1: Market Performance - As of September 30, 2023, 4799 private equity products reported an average return of 29.01%, outperforming the CSI 300 Index [2]. - The average return for private equity products with over 10 billion in assets was 28.70%, with an average offensive ability of 1.0266 and defensive ability of 0.1578 [3]. Group 2: Offensive and Defensive Capabilities - Offensive ability (upward capture rate) measures a fund's sensitivity to market increases, with higher values indicating stronger performance against the market. The formula is: (Portfolio cumulative return during benchmark increase + 1) / (Benchmark cumulative return during increase + 1) - 1 [3]. - Defensive ability (downward capture rate) measures a fund's sensitivity to market declines, with lower values being preferable. A negative value indicates positive returns during market downturns. The formula is: (Portfolio cumulative return during benchmark decrease + 1) / (Benchmark cumulative return during decrease + 1) - 1 [3]. Group 3: Top Private Equity Products - The top three private equity products with over 100 billion in assets are: 1. "复胜正能量二号" from 复胜资产 2. "开思瑋石" from 开思私募 3. "和谐汇一医疗创新B类份额" from 和谐汇一资产 [4][5]. - The top product in the 50-100 billion category is "远信中国积极成长C类份额" from 远信投资, followed by "康曼德003A号主动管理型" from 康曼德资本 [8][9]. - In the 20-50 billion category, "歌汝奇点" from 上海歌汝私募 ranks first, followed by "盛麒宝鉴" from 盛麒资产 [11][12]. - The leading product in the 10-20 billion category is "信持力定增精选28号" from 信持力资产 [14][15]. - The top product in the 5-10 billion category is "蓝宝石知行一号" from 蓝宝石基金 [18]. - In the 0-5 billion category, "子衿云杉" from 湖南子衿私募 ranks first [20][21].

Core Viewpoint - The A-share market showed strong performance in Q3 2025, with the ChiNext Index leading with a 50.4% increase, followed by the Shenzhen Component Index at 29.25% and the Shanghai Composite Index at 12.73% [1][2]. Group 1: Popular Private Fund Managers - The top five popular private fund managers in Q3 2025 are Dan Bin, Lin Yuan, Li Bei, Wu Yuefeng, and Zhu Xiaokang, with half of the top 20 being managers of funds over 10 billion [1][3]. - Dan Bin's funds have shown significant performance, with 75 products averaging ***% returns this year, and he has increased his focus on overseas investments, particularly in AI-related stocks [5][6]. - Lin Yuan, ranked second, has shifted to invest in a batch of Sci-Tech Innovation Board stocks, despite previously stating he would avoid tech stocks, indicating a strategic pivot [7][8]. - Li Bei, ranked third, manages products that have also performed well, with a focus on macro hedging strategies [8]. Group 2: Popular Private Fund Companies - The top private fund companies in Q3 2025 include Longqi Technology, Japan Investment, and Ningbo Huafang Quantitative, with a significant number of quantitative funds [9][10]. - Ningbo Huafang Quantitative has been recognized for its strong performance, with 11 products averaging ***% returns this year [13]. - Guoyuan Xinda, ranked 11th, has also performed well with its composite strategy products entering the top 20 for popularity [13]. Group 3: Popular Private Fund Products - The most popular private fund products are dominated by quantitative long products, with the top five managed by various fund managers, including Zou Kai from Hunan Zijin Private Fund and Shi Jianghui from Guoyuan Xinda [14][15]. - Hunan Zijin Private Fund's product has shown exceptional performance, leading the rankings for returns this year [15][17].

Core Viewpoint - The A-share market showed strong performance in August, with major indices rising significantly, yet the excess returns of stock strategy private equity products were disappointing, marking the worst monthly performance of the year [1][2]. Group 1: Market Performance - In August, the Shanghai Composite Index rose by 7.97%, the Shenzhen Component Index increased by 15.32%, and the ChiNext Index surged over 24% [1]. - Despite the strong market, the average excess return of 3,122 stock strategy private equity products was -1.97%, the worst monthly performance this year [1]. Group 2: Quantitative vs. Subjective Strategies - Quantitative private equity products experienced a notable decline, with an average excess return of -3.94% in August, while subjective private equity products had an average excess return of -1.00% [1]. - The significant decline in quantitative products is attributed to a reversal in style, particularly the outperformance of large-cap stocks over small-cap stocks, and severe sector differentiation due to rapid growth in financing scale [1][2]. Group 3: Consistent Performers - As of August 2025, only 95 stock strategy private equity products achieved positive excess returns for eight consecutive months, representing about 3% of the total [2]. - Among private equity firms with over 10 billion in assets, 46 products achieved positive excess returns for eight consecutive months, all of which were quantitative products, with an average excess return of 0.63% in August and 17.91% year-to-date [3]. Group 4: Top Performers by Asset Size - In the 20-100 billion category, 14 products achieved positive excess returns for eight consecutive months, with an average excess return of 1.83% in August and 22.48% year-to-date [7]. - The top three products in this category were "New Thinking Multi-Strategy 3", "Pansong Micro-Cap Index Enhanced 1", and "Giraffe 7", with year-to-date excess returns of ***% [11]. Group 5: Small and Emerging Firms - In the 5-20 billion category, 13 products achieved positive excess returns for eight consecutive months, with an average excess return of 5.34% in August and 57.58% year-to-date [13]. - The leading product in the 0-5 billion category was "Zijin Yunsong", achieving a year-to-date excess return of ***% [18].

Core Viewpoint - The A-share market has shown a strong performance, with the Shanghai Composite Index reaching 3700 points, indicating a recovery from previous economic shocks. A trend of gradual growth has emerged since April 27, following the impact of U.S. tariffs, leading to a widening gap between stock strategies and other primary strategies [1]. Summary by Categories Market Performance - The A-share market has entered a four-month trend of gradual growth, with a noticeable recovery in the index [1]. - Quantitative long strategies and subjective long strategies have both performed well, with quantitative long strategies achieving a return of 25.02% and subjective long strategies averaging 5.86% in July [3][4]. Strategy Performance - Among various strategies, subjective long strategies have outperformed quantitative long strategies due to their concentrated positions and flexibility in trading [4]. - The average return for subjective long strategies across different scales of private equity funds has been significant, with the highest returns observed in the 10-20 billion category at 25.43% [18]. Fund Performance - The top-performing subjective long products in the 100 billion category include "和谐汇一医疗创新B类份额" managed by 施跃, achieving a return of ***% [7][5]. - In the 50-100 billion category, "同犇22期" managed by 童驯 led with a return of ***% [14]. - The 20-50 billion category saw "丹羿鹏程1号1期" managed by 王帅 achieving a return of ***% [17]. - In the 10-20 billion category, "能敬价值优选二号" managed by 孙杰 led with a return of ***% [21]. - The 5-10 billion category was topped by "优波三号A类份额" managed by 陈龙 with a return of ***% [24]. - The 0-5 billion category saw "子衿云杉" managed by 邹凯 achieving a return of ***% [28]. Investment Insights - Fund managers are focusing on sectors such as innovative pharmaceuticals and medical devices, indicating a re-evaluation of high-quality assets in China [8]. - The market is currently in a phase where investors are cautious about the sustainability of earnings for companies that have seen significant price increases [8].

Core Viewpoint - The article emphasizes the importance of the Sharpe ratio as a key metric for evaluating the performance of private equity products, highlighting that a higher Sharpe ratio indicates better risk-adjusted returns and is a significant criterion for investors when selecting funds [1][3]. Summary by Categories 100 Billion and Above - Among the 432 stock strategy products, the average return from January to July is 18.45%, with an average Sharpe ratio of 2.56, indicating strong performance in the 100 billion and above category [2][3]. - The top three products in this category are managed by Wenbo Investment, Kuande Private Equity, and Evolution Asset, all of which are quantitative long strategies [3]. 50-100 Billion - In the 50-100 billion category, there are 158 stock strategy products with an average return of 16.32% and an average Sharpe ratio of 2.21 [6]. - The leading products are from Pingfang Investment, Dadao Investment, and Tiansuan Quantitative, showcasing a mix of quantitative and subjective strategies [6]. 20-50 Billion - The 20-50 billion category includes 265 stock strategy products, with an average return of 18.80% and an average Sharpe ratio of 2.26 [10]. - The top products are managed by Jiuming Investment, Xiangmu Asset, and Zhaorong Hui Li Private Equity, indicating a strong performance in this segment [10]. 10-20 Billion - In the 10-20 billion category, the average return is 23.84% with an average Sharpe ratio of 2.02 [12]. - The leading product is managed by Yangshi Asset, reflecting a notable performance in this size category [12]. 5-10 Billion - The 5-10 billion category has 387 stock strategy products, with an average return of 21.08% and an average Sharpe ratio of 1.69 [16]. - The top products are from Manfeng Asset, Hanxin Fund, and Mingyu Investment, indicating competitive performance [16]. 0-5 Billion - In the 0-5 billion category, there are 1173 stock strategy products with an average return of 17.57% and an average Sharpe ratio of 1.60 [21]. - The leading products are from Hunan Zijin Private Equity, Guangzhou Tianzhanhan, and Quancheng Fund, showing a diverse range of strategies [21].